ROPIVACAINE VIATRIS 10 mg/ml, solution for injection in an ampoule 5 ampoules of 20 ml
Active ingredients: Ropivacaine hydrochloride, ROPIVACAÏNE BASE
Commercialized according to BDPMDispensing in France: Prescription only
Solution for injection5 ampoules of 20 mlinfiltration;péridurale;périneurale
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- ROPIVACAINE VIATRIS 10 mg/ml, solution injectable en ampoule
- Pharmaceutical form
- solution injectable
- Route of administration
- infiltration;péridurale;périneurale
- Presentation description
- 5 ampoule(s) polypropylène suremballée(s)/surpochée(s) de 20 ml
- Marketing authorisation holder
- VIATRIS SANTE
- Reimbursement according to BDPM
- —
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 4 Jan 2010
- Prescription and dispensing conditions
- Prescription only
- List II: prescription-only medicine
- Prescribed by a hospital doctor
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
62232322CIP75745271CIP133400957452711Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| ROPIVACAÏNE BASEsolution | 8,83 mg · 1 ml de solution injectable | FT |
| CHLORHYDRATE DE ROPIVACAÏNEsolution | 10 mg · 1 ml de solution injectable | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Other packages of this medicine
The same medicine in another pack size, according to BDPM.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.